SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-020836
Filing Date
2020-05-04
Accepted
2020-05-04 16:17:01
Documents
58
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kura-10q_20200331.htm   iXBRL 10-Q 1866940
2 EX-10.1 kura-ex101_123.htm EX-10.1 98543
3 EX-10.2 kura-ex102_125.htm EX-10.2 48835
4 EX-10.5 kura-ex105_32.htm EX-10.5 841951
5 EX-10.7 kura-ex107_85.htm EX-10.7 15866
6 EX-10.8 kura-ex108_222.htm EX-10.8 34060
7 EX-31.1 kura-ex311_8.htm EX-31.1 17441
8 EX-31.2 kura-ex312_7.htm EX-31.2 17251
9 EX-32.1 kura-ex321_10.htm EX-32.1 9541
  Complete submission text file 0001564590-20-020836.txt   7028097

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA kura-20200331.xsd EX-101.SCH 37073
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kura-20200331_cal.xml EX-101.CAL 42052
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kura-20200331_def.xml EX-101.DEF 103841
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20200331_lab.xml EX-101.LAB 277628
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20200331_pre.xml EX-101.PRE 206027
15 EXTRACTED XBRL INSTANCE DOCUMENT kura-10q_20200331_htm.xml XML 1048718
Mailing Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121
Business Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37620 | Film No.: 20845078
SIC: 2834 Pharmaceutical Preparations